Maiden (MHLD) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Reported net loss of $34.5 million for Q3 2024 and $43.0 million for the nine months ended September 30, 2024, driven by adverse prior year reserve development and lower investment income.
Book value per common share decreased 15.7% to $2.09; non-GAAP book value per share down 6.6% to $2.98 as of September 30, 2024.
Strategic focus shifted to divesting IIS businesses, reducing alternative investments, and repositioning the balance sheet for liquidity and capital management.
No new reinsurance underwriting; legacy business in run-off, with significant adverse development in AmTrust Reinsurance segment.
Financial highlights
Net premiums earned increased 7.4% year-over-year to $13.4 million for Q3 and 16.5% to $37.9 million for the nine months, mainly from growth in Credit Life programs.
Underwriting loss widened to $18.8 million for Q3 and $36.0 million for the nine months, primarily due to adverse prior year development in AmTrust Reinsurance.
Net investment income fell 46.1% to $4.9 million for Q3 and 32.9% to $19.5 million for the nine months, reflecting lower funds withheld balances and higher investment expenses.
Net realized and unrealized investment losses of $3.8 million in Q3, but gains of $6.4 million for the nine months, driven by sales/redemptions of alternative investments.
Annualized non-GAAP operating ROACE was (20.4)% for Q3 and (13.5)% for the nine months.
Outlook and guidance
Company expects further premium declines as Maiden LF and Maiden GF exit new business and divest IIS operations.
Actively pursuing finality solutions for AmTrust liabilities not covered by the LPT/ADC Agreement, which may involve significant charges.
Ongoing focus on capital management, including share and debt repurchases, and increasing liquidity to support strategic initiatives.